{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:11:16Z","timestamp":1790017876845,"version":"4.0.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["631904"],"award-info":[{"award-number":["631904"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS109304"],"award-info":[{"award-number":["1R01NS109304"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["T32HD040127"],"award-info":[{"award-number":["T32HD040127"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08794-2","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:29:04Z","timestamp":1756819744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["AAV-dCas9 vector unsilences paternal Ube3a in neurons by impeding Ube3a-ATS transcription"],"prefix":"10.1038","volume":"8","author":[{"given":"Justin M.","family":"Wolter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-9299","authenticated-orcid":false,"given":"Lucas M.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Boeshore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9114-9836","authenticated-orcid":false,"given":"Giulia","family":"Fragola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Taylor-Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-0513","authenticated-orcid":false,"given":"Jason L.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0911-7902","authenticated-orcid":false,"given":"Mark J.","family":"Zylka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"8794_CR1","doi-asserted-by":"publisher","unstructured":"Dagli, A. I., Mueller, J. & Williams, C. A. Angelman Syndrome. in GeneReviews\u00ae (eds. Adam, M. P. et al.) (University of Washington, Seattle, 1993) https:\/\/doi.org\/10.1002\/9781119432692.ch5.","DOI":"10.1002\/9781119432692.ch5"},{"key":"8794_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting, K., Williams, C. & Horsthemke, B. Angelman syndrome - insights into a rare neurogenetic disorder. Nat. Rev. Neurol. 12, 584\u2013593 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"8794_CR3","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1073\/pnas.1815279116","volume":"116","author":"JS Hsiao","year":"2019","unstructured":"Hsiao, J. S. et al. A bipartite boundary element restricts UBE3A imprinting to mature neurons. Proc. Natl Acad. Sci. USA 116, 2181\u20132186 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8794_CR4","doi-asserted-by":"publisher","first-page":"1410791","DOI":"10.3389\/fnana.2024.1410791","volume":"18","author":"C Gonzalez Ramirez","year":"2024","unstructured":"Gonzalez Ramirez, C. et al. Regional and cellular organization of the autism-associated protein UBE3A\/E6AP and its antisense transcript in the brain of the developing rhesus monkey. Front. Neuroanat. 18, 1410791 (2024).","journal-title":"Front. Neuroanat."},{"key":"8794_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49788-8","volume":"15","author":"H Vihma","year":"2024","unstructured":"Vihma, H. et al. Ube3a unsilencer for the potential treatment of Angelman syndrome. Nat. Commun. 15, 5558 (2024).","journal-title":"Nat. Commun."},{"key":"8794_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature10726","volume":"481","author":"H-S Huang","year":"2011","unstructured":"Huang, H.-S. et al. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481, 185\u2013189 (2011).","journal-title":"Nature"},{"key":"8794_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature13975","volume":"518","author":"L Meng","year":"2015","unstructured":"Meng, L. et al. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature 518, 409\u2013412 (2015).","journal-title":"Nature"},{"key":"8794_CR8","doi-asserted-by":"publisher","first-page":"e145991","DOI":"10.1172\/jci.insight.145991","volume":"6","author":"C Milazzo","year":"2021","unstructured":"Milazzo, C. et al. Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model. JCI Insight 6, e145991 (2021).","journal-title":"JCI Insight"},{"key":"8794_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf4077","volume":"15","author":"SV Dindot","year":"2023","unstructured":"Dindot, S. V. et al. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript. Sci. Transl. Med. 15, eabf4077 (2023).","journal-title":"Sci. Transl. Med."},{"key":"8794_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2835-2","volume":"587","author":"JM Wolter","year":"2020","unstructured":"Wolter, J. M. et al. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Nature 587, 281\u2013284 (2020).","journal-title":"Nature"},{"key":"8794_CR11","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1016\/j.ymthe.2024.09.032","volume":"32","author":"HO Bazick","year":"2024","unstructured":"Bazick, H. O., Mao, H., Niehaus, J. K., Wolter, J. M. & Zylka, M. J. AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription. Mol. Ther. 32, 4122\u20134137 (2024).","journal-title":"Mol. Ther."},{"key":"8794_CR12","doi-asserted-by":"publisher","first-page":"e142574","DOI":"10.1172\/JCI142574","volume":"131","author":"RS Schmid","year":"2021","unstructured":"Schmid, R. S. et al. CRISPR\/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice. J. Clin. Invest. 131, e142574 (2021).","journal-title":"J. Clin. Invest."},{"key":"8794_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/hum.2017.009","volume":"28","author":"RJ Chandler","year":"2017","unstructured":"Chandler, R. J., Sands, M. S. & Venditti, C. P. Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models. Hum. Gene Ther. 28, 314\u2013322 (2017).","journal-title":"Hum. Gene Ther."},{"key":"8794_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1172\/JCI79213","volume":"125","author":"RJ Chandler","year":"2015","unstructured":"Chandler, R. J. et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.  J. Clin. Investig. 125, 870\u2013880 (2015).","journal-title":"J. Clin. Investig."},{"key":"8794_CR15","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/mt.2012.197","volume":"20","author":"LE Rosas","year":"2012","unstructured":"Rosas, L. E. et al. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity. Mol. Ther. 20, 2098\u20132110 (2012).","journal-title":"Mol. Ther."},{"key":"8794_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"J-C Nault","year":"2015","unstructured":"Nault, J.-C. et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat. Genet. 47, 1187\u20131193 (2015).","journal-title":"Nat. Genet."},{"key":"8794_CR17","first-page":"2316","volume":"141","author":"A Calabria","year":"2023","unstructured":"Calabria, A. et al. Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice. Blood 141, 2316\u20132329 (2023).","journal-title":"Blood"},{"key":"8794_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ymthe.2020.10.018","volume":"29","author":"DA Dalwadi","year":"2021","unstructured":"Dalwadi, D. A. et al. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Mol. Ther. 29, 680\u2013690 (2021).","journal-title":"Mol. Ther."},{"key":"8794_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo4662","volume":"8","author":"GM Welch","year":"2022","unstructured":"Welch, G. M. et al. Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. Sci. Adv. 8, eabo4662 (2022).","journal-title":"Sci. Adv."},{"key":"8794_CR20","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1016\/j.cell.2023.08.038","volume":"186","author":"V Dileep","year":"2023","unstructured":"Dileep, V. et al. Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration. Cell 186, 4404\u20134421.e20 (2023).","journal-title":"Cell"},{"key":"8794_CR21","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8, 2180\u20132196 (2013).","journal-title":"Nat. Protoc."},{"key":"8794_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore, P. I. et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143\u20131149 (2015).","journal-title":"Nat. Methods"},{"key":"8794_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647\u2013661 (2014).","journal-title":"Cell"},{"key":"8794_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41421-024-00727-3","volume":"10","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Epigenetic editing alleviates Angelman syndrome phenotype in mice by unsilencing paternal Ube3a. Cell Discov. 10, 97 (2024).","journal-title":"Cell Discov."},{"key":"8794_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/mt.2015.236","volume":"24","author":"BJ Bailus","year":"2016","unstructured":"Bailus, B. J. et al. Protein delivery of an artificial transcription factor restores widespread ube3a expression in an angelman syndrome mouse brain. Mol. Ther. 24, 548\u2013555 (2016).","journal-title":"Mol. Ther."},{"key":"8794_CR26","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1093\/nar\/gkh670","volume":"32","author":"M Landers","year":"2004","unstructured":"Landers, M. et al. Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf\/Snrpn. Nucleic Acids Res 32, 3480\u20133492 (2004).","journal-title":"Nucleic Acids Res"},{"key":"8794_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ymthe.2023.01.013","volume":"31","author":"H O\u2019Geen","year":"2023","unstructured":"O\u2019Geen, H. et al. Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model. Mol. Ther. 31, 1088\u20131105 (2023).","journal-title":"Mol. Ther."},{"key":"8794_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54573-8","volume":"15","author":"A Helwak","year":"2024","unstructured":"Helwak, A., Turowski, T., Spanos, C. & Tollervey, D. Roles of SNORD115 and SNORD116 ncRNA clusters during neuronal differentiation. Nat. Commun. 15, 10427 (2024).","journal-title":"Nat. Commun."},{"key":"8794_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ejhg.2014.103","volume":"23","author":"E Bieth","year":"2015","unstructured":"Bieth, E. et al. Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome. Eur. J. Hum. Genet. 23, 252\u2013255 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"8794_CR30","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173\u20131183 (2013).","journal-title":"Cell"},{"key":"8794_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"8794_CR32","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1093\/nar\/gkt520","volume":"41","author":"D Bikard","year":"2013","unstructured":"Bikard, D. et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 41, 7429\u20137437 (2013).","journal-title":"Nucleic Acids Res"},{"key":"8794_CR33","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41594-023-01090-9","volume":"30","author":"I Zukher","year":"2023","unstructured":"Zukher, I., Dujardin, G., Sousa-Lu\u00eds, R. & Proudfoot, N. J. Elongation roadblocks mediated by dCas9 across human genes modulate transcription and nascent RNA processing. Nat. Struct. Mol. Biol. 30, 1536\u20131548 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"8794_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molcel.2017.09.033","volume":"68","author":"BS Pinto","year":"2017","unstructured":"Pinto, B. S. et al. Impeding transcription of expanded microsatellite repeats by deactivated cas9. Mol. Cell 68, 479\u2013490.e5 (2017).","journal-title":"Mol. Cell"},{"key":"8794_CR35","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41594-022-00864-x","volume":"29","author":"PM Hall","year":"2022","unstructured":"Hall, P. M. et al. Polarity of the CRISPR roadblock to transcription. Nat. Struct. Mol. Biol. 29, 1217\u20131227 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"8794_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.stem.2016.01.022","volume":"18","author":"MA Mandegar","year":"2016","unstructured":"Mandegar, M. A. et al. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. Cell Stem Cell 18, 541\u2013553 (2016).","journal-title":"Cell Stem Cell"},{"key":"8794_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/17425247.2018.1517746","volume":"15","author":"DC Luther","year":"2018","unstructured":"Luther, D. C., Lee, Y. W., Nagaraj, H., Scaletti, F. & Rotello, V. M. Delivery approaches for CRISPR\/Cas9 therapeutics in vivo: advances and challenges. Expert Opin. Drug Deliv. 15, 905\u2013913 (2018).","journal-title":"Expert Opin. Drug Deliv."},{"key":"8794_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41586-022-05114-0","volume":"609","author":"M Pacesa","year":"2022","unstructured":"Pacesa, M. et al. R-loop formation and conformational activation mechanisms of Cas9. Nature 609, 191\u2013196 (2022).","journal-title":"Nature"},{"key":"8794_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/mt.2016.8","volume":"24","author":"CM Lee","year":"2016","unstructured":"Lee, C. M., Cradick, T. J. & Bao, G. The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells. Mol. Ther. 24, 645\u2013654 (2016).","journal-title":"Mol. Ther."},{"key":"8794_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25339-3","volume":"12","author":"EA Moreb","year":"2021","unstructured":"Moreb, E. A. & Lynch, M. D. Genome dependent Cas9\/gRNA search time underlies sequence dependent gRNA activity. Nat. Commun. 12, 5034 (2021).","journal-title":"Nat. Commun."},{"key":"8794_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/crispr.2024.0074","volume":"8","author":"RM Major","year":"2025","unstructured":"Major, R. M. et al. Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions.  CRISPR J. 8, 120\u2013136 (2025).","journal-title":"CRISPR J."},{"key":"8794_CR42","doi-asserted-by":"publisher","first-page":"e0188830","DOI":"10.1371\/journal.pone.0188830","volume":"12","author":"SL Hammond","year":"2017","unstructured":"Hammond, S. L., Leek, A. N., Richman, E. H. & Tjalkens, R. B. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection. PLoS ONE 12, e0188830 (2017).","journal-title":"PLoS ONE"},{"key":"8794_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuron.2019.05.047","volume":"103","author":"Y Gao","year":"2019","unstructured":"Gao, Y. et al. Plug-and-Play Protein Modification Using Homology-Independent Universal Genome Engineering. Neuron 103, 583\u2013597.e8 (2019).","journal-title":"Neuron"},{"key":"8794_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","volume":"10","author":"C Burger","year":"2004","unstructured":"Burger, C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10, 302\u2013317 (2004).","journal-title":"Mol. Ther."},{"key":"8794_CR45","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI80554","volume":"125","author":"S Silva-Santos","year":"2015","unstructured":"Silva-Santos, S. et al. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.  J. Clin. Investig. 125, 2069\u20132076 (2015).","journal-title":"J. Clin. Investig."},{"key":"8794_CR46","doi-asserted-by":"publisher","first-page":"e144712","DOI":"10.1172\/jci.insight.144712","volume":"6","author":"MC Judson","year":"2021","unstructured":"Judson, M. C. et al. Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice. JCI Insight 6, e144712 (2021).","journal-title":"JCI Insight"},{"key":"8794_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2020.02.017","volume":"445","author":"DC Rotaru","year":"2020","unstructured":"Rotaru, D. C., Mientjes, E. J. & Elgersma, Y. Angelman syndrome: from mouse models to therapy. Neuroscience 445, 172\u2013189 (2020).","journal-title":"Neuroscience"},{"key":"8794_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","volume":"21","author":"YH Jiang","year":"1998","unstructured":"Jiang, Y. H. et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799\u2013811 (1998).","journal-title":"Neuron"},{"key":"8794_CR49","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/cne.23507","volume":"522","author":"MC Judson","year":"2014","unstructured":"Judson, M. C., Sosa-Pagan, J. O., Del Cid, W. A., Han, J. E. & Philpot, B. D. Allelic specificity of Ube3a expression in the mouse brain during postnatal development. J. Comp. Neurol. 522, 1874\u20131896 (2014).","journal-title":"J. Comp. Neurol."},{"key":"8794_CR50","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"8794_CR51","doi-asserted-by":"publisher","first-page":"e72290","DOI":"10.7554\/eLife.72290","volume":"11","author":"H Kim","year":"2022","unstructured":"Kim, H. et al. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression. eLife 11, e72290 (2022).","journal-title":"eLife"},{"key":"8794_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004039","volume":"9","author":"L Meng","year":"2013","unstructured":"Meng, L. et al. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. PLoS Genet 9, e1004039 (2013).","journal-title":"PLoS Genet"},{"key":"8794_CR53","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20177899","volume":"14","author":"A Vigouroux","year":"2018","unstructured":"Vigouroux, A., Oldewurtel, E., Cui, L., Bikard, D. & van Teeffelen, S. Tuning dCas9\u2019s ability to block transcription enables robust, noiseless knockdown of bacterial genes. Mol. Syst. Biol. 14, e7899 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"8794_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.molcel.2018.06.005","volume":"71","author":"R Clarke","year":"2018","unstructured":"Clarke, R. et al. Enhanced Bacterial Immunity and Mammalian Genome Editing via RNA-Polymerase-Mediated Dislodging of Cas9 from Double-Strand DNA Breaks. Mol. Cell 71, 42\u201355.e8 (2018).","journal-title":"Mol. Cell"},{"key":"8794_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49837-z","volume":"9","author":"KS Whinn","year":"2019","unstructured":"Whinn, K. S. et al. Nuclease dead Cas9 is a programmable roadblock for DNA replication. Sci. Rep. 9, 13292 (2019).","journal-title":"Sci. Rep."},{"key":"8794_CR56","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1261\/rna.071613.119","volume":"25","author":"JR Widom","year":"2019","unstructured":"Widom, J. R., Rai, V., Rohlman, C. E. & Walter, N. G. Versatile transcription control based on reversible dCas9 binding. RNA 25, 1457\u20131469 (2019).","journal-title":"RNA"},{"key":"8794_CR57","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"8794_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nmeth.2331","volume":"10","author":"M Ranzani","year":"2013","unstructured":"Ranzani, M. et al. Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer. Nat. Methods 10, 155\u2013161 (2013).","journal-title":"Nat. Methods"},{"key":"8794_CR59","doi-asserted-by":"publisher","first-page":"ENEURO.0495-18.","DOI":"10.1523\/ENEURO.0495-18.2019","volume":"6","author":"KE Savell","year":"2019","unstructured":"Savell, K. E. et al. A Neuron-Optimized CRISPR\/dCas9 Activation System for Robust and Specific Gene Regulation. eNeuro 6, ENEURO.0495-18.2019 (2019).","journal-title":"eNeuro"},{"key":"8794_CR60","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1093\/nar\/gkv601","volume":"43","author":"D-JJ Truong","year":"2015","unstructured":"Truong, D.-J. J. et al. Development of an intein-mediated split-Cas9 system for gene therapy. Nucleic Acids Res. 43, 6450\u20136458 (2015).","journal-title":"Nucleic Acids Res"},{"key":"8794_CR61","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ymthe.2021.07.011","volume":"30","author":"S Zhi","year":"2022","unstructured":"Zhi, S. et al. Dual-AAV delivering split prime editor system for in vivo genome editing. Mol. Ther. 30, 283\u2013294 (2022).","journal-title":"Mol. Ther."},{"key":"8794_CR62","doi-asserted-by":"publisher","first-page":"eaau0629","DOI":"10.1126\/science.aau0629","volume":"363","author":"N Matharu","year":"2019","unstructured":"Matharu, N. et al. CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Science 363, eaau0629 (2019).","journal-title":"Science"},{"key":"8794_CR63","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"8794_CR64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell, S. et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390, 849\u2013860 (2017).","journal-title":"Lancet"},{"key":"8794_CR65","doi-asserted-by":"publisher","first-page":"e81892","DOI":"10.7554\/eLife.81892","volume":"12","author":"D Lee","year":"2023","unstructured":"Lee, D. et al. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome. eLife 12, e81892 (2023).","journal-title":"eLife"},{"key":"8794_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"8794_CR67","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ajmg.a.33775","volume":"155A","author":"W-H Tan","year":"2011","unstructured":"Tan, W.-H. et al. Angelman syndrome: Mutations influence features in early childhood. Am. J. Med. Genet. A 155A, 81\u201390 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"8794_CR68","doi-asserted-by":"publisher","first-page":"e158953","DOI":"10.1172\/jci.insight.158953","volume":"7","author":"AM Punt","year":"2022","unstructured":"Punt, A. M. et al. Molecular and behavioral consequences of Ube3a gene overdosage in mice. JCI Insight 7, e158953 (2022).","journal-title":"JCI Insight"},{"key":"8794_CR69","doi-asserted-by":"publisher","first-page":"e0156439","DOI":"10.1371\/journal.pone.0156439","volume":"11","author":"AM Mabb","year":"2016","unstructured":"Mabb, A. M. et al. Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms. PLoS ONE 11, e0156439 (2016).","journal-title":"PLoS ONE"},{"key":"8794_CR70","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"8794_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature12504","volume":"501","author":"IF King","year":"2013","unstructured":"King, I. F. et al. Topoisomerases facilitate transcription of long genes linked to autism. Nature 501, 58\u201362 (2013).","journal-title":"Nature"},{"key":"8794_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1165\/rcmb.2007-0133OC","volume":"39","author":"AA Wilson","year":"2008","unstructured":"Wilson, A. A. et al. Sustained expression of alpha1-antitrypsin after transplantation of manipulated hematopoietic stem cells. Am. J. Respir. Cell Mol. Biol. 39, 133\u2013141 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"8794_CR73","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"8794_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuron.2014.05.035","volume":"83","author":"JL Stein","year":"2014","unstructured":"Stein, J. L. et al. A quantitative framework to evaluate modeling of cortical development by neural stem cells. Neuron 83, 69\u201386 (2014).","journal-title":"Neuron"},{"key":"8794_CR75","doi-asserted-by":"publisher","unstructured":"Kim, J.-Y., Grunke, S. D., Levites, Y., Golde, T. E. & Jankowsky, J. L. Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction. J. Vis. Exp. 51863 https:\/\/doi.org\/10.3791\/51863 (2014).","DOI":"10.3791\/51863"},{"key":"8794_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0231-7","volume":"9","author":"M Sonzogni","year":"2018","unstructured":"Sonzogni, M. et al. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants. Mol. Autism 9, 47 (2018).","journal-title":"Mol. Autism"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08794-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:26:19Z","timestamp":1756902379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08794-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8794"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08794-2","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1332"}}